Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biote Corp. - Class A common stock (NQ: BTMD ) 7.470 +0.080 (+1.08%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,057,148 Open 7.480 Bid (Size) 7.130 (1) Ask (Size) 7.760 (2) Prev. Close 7.390 Today's Range 7.320 - 7.550 52wk Range 3.654 - 8.220 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares June 20, 2024 From biote Corp. Via Business Wire BTMD Stock Earnings: Biote Misses EPS, Beats Revenue for Q1 2024 May 07, 2024 BTMD stock results show that Biote missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace Performance YTD +57.93% +57.93% 1 Month +12.16% +12.16% 3 Month +30.59% +30.59% 6 Month +57.93% +57.93% 1 Year +10.34% +10.34% More News Read More Biote Reports First Quarter 2024 Financial Results May 07, 2024 From Biote Via Business Wire Biote Announces Definitive Settlement with Founder April 29, 2024 From biote Corp. Via Business Wire Biote: Q4 Earnings Insights March 12, 2024 Via Benzinga Preview: Biote's Earnings March 11, 2024 Via Benzinga Biote Schedules First Quarter 2024 Financial Results Release and Conference Call April 23, 2024 From biote Corp. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session March 29, 2024 Via Benzinga Biote Reports Fourth Quarter and Full Year 2023 Financial Results March 12, 2024 From Biote Via Business Wire Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call February 27, 2024 From Biote Corp. Via Business Wire Earnings Scheduled For March 12, 2024 March 12, 2024 Via Benzinga Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares February 20, 2024 From biote Corp. Via Business Wire Biote Announces $20 Million Share Repurchase Authorization January 25, 2024 From biote Corp. Via Business Wire Biote Provides Preliminary 2023 Results and Initial 2024 Guidance January 17, 2024 From biote Corp. Via Business Wire Biote to Purchase Asteria Health January 17, 2024 From biote Corp. Via Business Wire Biote Names Robert Peterson as Chief Financial Officer January 11, 2024 From biote Corp. Via Business Wire Biote Reports Third Quarter 2023 Financial Results November 07, 2023 From Biote Via Business Wire Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call October 24, 2023 From biote Corp. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session August 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session August 11, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session August 10, 2023 Via Benzinga Biote Reports Second Quarter 2023 Financial Results August 10, 2023 From Biote Via Business Wire Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call July 27, 2023 From biote Corp. Via Business Wire Biote Formalizes Commitment to Men’s Hormone Health With Launch of New Men’s Health Division June 22, 2023 From biote Corp. Via Business Wire InvestorNewsBreaks – Biote Corp. (NASDAQ: BTMD) Closes $31M Underwritten Public Offering June 13, 2023 Via Investor Brand Network Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.